期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

质粒介导细菌对喹诺酮类抗菌药物的耐药机制 被引量：11

原文传递
导出
作者 马晓波 宋秀宇
机构地区 福建医科大学附属厦门第一医院检验科
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2009年第12期1618-1620,共3页 Chinese Journal of Nosocomiology
基金 厦门市科技局资助项目(3502Z20084003)
关键词 质粒介导 耐药 喹诺酮类药物 QNR aac-(6’)-Ⅰ b-cr QEPA
分类号 R378.1 [医药卫生—病原生物学]
  • 相关文献

参考文献15

  • 1李家泰,李耘,齐慧敏,代表中国细菌耐药监测研究组.2002—2003年中国革兰阴性细菌耐药性监测研究[J].中华检验医学杂志,2005,28(1):19-29. 被引量：296
  • 2Jacoby GA. Mechanisms of resistance to quinolones[J]. Clin Infect Dis, 2005,41 (Suppl 2) : S120-S126.
  • 3Martinez LM,Paseual A,Jacoby GA. Quinolone resistance from a transferable plasmid[J]. Lancet, 1998,351 : 797-799.
  • 4Robicsek A, Strahilevitz J, Jacoby GA, et al. Fluoroquinolo ne-modifying enzyme: a new adaptation of a common amin oglycoside aeetyltransferase[J]. Nat Med, 2006, 12 ( 1 ) : 83-88.
  • 5Yamane KJ,Wachino S, Suzuki K,et al. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate[J]. Antimicrob Agents Chemother, 2007,51(9) :3354-3360.
  • 6Li XZ. Quinolone resistance in bacteria: emphasis on plasmidmediated mechanisms[J]. Int J Antimicrob Agents,2005,25 : 453-463.
  • 7Suzuki MHM, Matsumoto M, Takahashi M, et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flezneri 2b[J]. Antimicrob Agents Chemother,2005,49(2) :801-803.
  • 8Jacoby GA,Kelley E,Walsh,etal. qnrB, Another plasrnid-mediated gene for quinolone resistance[J]. Antimicrob Agents Chemother,200fi,50(4) :1178-1182.
  • 9Tran JH,Jacoby GA, Hooper DC. Interaction of the plasmidencoded quinolone resistance protein qnrA with Escherlchia coli topoisomerase Ⅳ [J]. Antimicrob Agents Chemother, 2005,49(7) : 3050-3052.
  • 10Wang MG,Tran JH,Jacoby GA,et al. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China[J]. Antimicrob Agents Chemother, 2003, 47 (7): 2242- 2248.

二级参考文献7

  • 1National Committee for Clinical Laboratory Standard, 2002. Performance Standards for Antimicrobial Susceptibility Testing. NCCLS, Wayne, Pa.
  • 2Rhomberg PR, Jones RN , MYSTIC Study Group. Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials:report from the MYSTIC Program (2002) in North America. Diagn Microbiol Infect Dis, 2003,47:365-372.
  • 3Pfaller MA, Jones RN , MYSTIC Study Group. Antimicrobial susceptibility of inducible Amp C β-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents, 2002,19:383-388.
  • 4Sader HS, Biedenbach DJ ,Jones RN. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis, 2003,47:361-364.
  • 5Sader HS, Gales AC, Pfaller MA, et al. Pathogen frequency and resistance patterns in Brazilian hospitals:summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis, 2001,5:200-214.
  • 6李家泰,AllanJ Weinstein,杨敏,中国细菌耐药监测研究组.中国细菌耐药监测研究[J].中华医学杂志,2001,81(1):8-16. 被引量：376
  • 7李家泰,李耘,王进,中国细菌耐药监测研究组.中国医院和社区获得性感染革兰阳性球菌耐药性监测研究[J].中华医学杂志,2003,83(5):365-374. 被引量：198

共引文献295

同被引文献85

引证文献11

二级引证文献54

中华医院感染学杂志
2009年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部